Four Thought Financial Partners, LLC Novartis Ag Transaction History

Four Thought Financial Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $54,469 - $60,449	-575 Reduced 10.58%	4,862 $495 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $88,356 - $100,189	-955 Reduced 14.94%	5,437 $549 Million
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $56,341 - $65,338	-704 Reduced 9.92%	6,392 $588 Million
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $536,102 - $656,521	7,096 New	7,096 $644 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $228B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.